Bio-Path Ownership | Who Owns Bio-Path?


OverviewRevenueFinancialsChartTranscripts

Bio-Path Ownership Summary


Bio-Path is owned by 5.94% institutional investors, and 94.06% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.36% of its assets in Bio-Path shares.

BPTH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBio-Path5.94%-94.06%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202320-4.76%597,115-14.00%57.81%9-18.18%2-33.33%
Sep 30, 20232123.53%694,29451.98%826.48%11266.67%350.00%
Jun 30, 202317-15.00%456,833-19.92%511.17%3-62.50%2-33.33%
Mar 31, 20232011.11%570,438-11.76%79.08%8-33.33%350.00%
Dec 31, 20221838.46%646,46040.75%821.59%1271.43%2100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr13.50K0.36%-
Fidelity Extended Market Index12.19K0.33%3.03K
NT Ext Equity Mkt Idx Fd - NL550.000.02%-
Fidelity Nasdaq Composite Index755.000.02%-
NT Ext Equity Mkt Idx Fd - DC - NL - T2443.000.02%1.00
Fidelity Series Total Market Index485.000.01%-
Northern Trust Extended Eq Market Idx305.000.01%-
NT Ext Equity Mkt Idx Fd - L305.000.01%-
Fidelity Total Market Index170.000.00%-
NT Ext Eq Mkt Indx Fd DC Lending Tier 547.000.00%-

Recent Insider Transactions


DateNameRoleActivityValue
Jan 18, 2019ARMISTICE CAPITAL, LLC-Sell-
Jan 18, 2019ARMISTICE CAPITAL, LLC-Sell$171.64K
Jul 13, 2015Garrison Michael J.-Buy$8.96K
Jul 09, 2015Garrison Michael J.-Buy$10.21K
Jul 08, 2015Garrison Michael J.-Buy$25.22K

Insider Transactions Trends


DateBuySell
2024 Q3--
2023 Q2--
2022 Q1--
2021 Q1--
2020 Q2--

BPTH Ownership FAQ


Who Owns Bio-Path?

Bio-Path shareholders are primarily institutional investors at 5.94%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Bio-Path's industry, Biotech Stocks , is 47.04%, which Bio-Path falls below.

Does Blackrock own Bio-Path?

BlackRock is not among the top 10 institutional shareholders of Bio-Path.

Who is the top mutual fund holder of Bio-Path shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Bio-Path shares, with 0.36% of its total shares outstanding invested in 13.5K Bio-Path shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools